Podcast : Reversal of Novel Anticoagulant agents in critically ill patients - an interview with Scott Kaatz

The introduction of new and novel agents into practice always leads to a period of uncertainty. Clinical trials of new pharmaceuticals can only tell us so much about the side effect profile, and many lessons are learned the hard way.

In this new SCCM podcast, I chat to Dr Scott Kaatz about bleeding management and reversal strategies for the DOAC patient.  Scott is Senior Staff Hospitalist and Medical Director for Professional Development and Research in the Division of Hospital Medicine at Henry Ford Hospital in Detroit, Michigan.

SCCM Pod-331 Bleeding Management and Reversal Strategies for the DOAC Patient: New and Future Approaches